This company listing is no longer active
Apollo Endosurgery Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Información clave
3.0%
Tasa de crecimiento de los beneficios
21.2%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 4.3% |
| Tasa de crecimiento de los ingresos | 1.9% |
| Rentabilidad financiera | -122.2% |
| Margen neto | -51.8% |
| Última actualización de beneficios | 31 Dec 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Apollo Endosurgery. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 22 | 77 | -40 | 57 | 12 |
| 30 Sep 22 | 72 | -41 | 53 | 11 |
| 30 Jun 22 | 68 | -36 | 50 | 11 |
| 31 Mar 22 | 66 | -28 | 47 | 10 |
| 31 Dec 21 | 63 | -25 | 43 | 10 |
| 30 Sep 21 | 60 | -18 | 39 | 9 |
| 30 Jun 21 | 56 | -14 | 35 | 8 |
| 31 Mar 21 | 45 | -17 | 28 | 7 |
| 31 Dec 20 | 42 | -23 | 28 | 8 |
| 30 Sep 20 | 41 | -26 | 31 | 8 |
| 30 Jun 20 | 40 | -32 | 34 | 8 |
| 31 Mar 20 | 48 | -35 | 41 | 9 |
| 31 Dec 19 | 51 | -27 | 42 | 10 |
| 30 Sep 19 | 54 | -39 | 44 | 11 |
| 30 Jun 19 | 57 | -40 | 45 | 13 |
| 31 Mar 19 | 58 | -40 | 45 | 13 |
| 31 Dec 18 | 61 | -46 | 46 | 12 |
| 30 Sep 18 | 62 | -35 | 46 | 11 |
| 30 Jun 18 | 64 | -30 | 47 | 10 |
| 31 Mar 18 | 66 | -27 | 47 | 9 |
| 31 Dec 17 | 64 | -27 | 47 | 8 |
| 30 Sep 17 | 64 | -33 | 44 | 9 |
| 30 Jun 17 | 63 | -36 | 44 | 9 |
| 31 Mar 17 | 63 | -41 | 43 | 8 |
| 31 Dec 16 | 65 | -41 | 42 | 8 |
| 30 Sep 16 | 66 | -36 | 43 | 7 |
| 30 Jun 16 | 66 | -38 | 44 | 8 |
Ingresos de calidad: HQ8F is currently unprofitable.
Margen de beneficios creciente: HQ8F is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: HQ8F is unprofitable, but has reduced losses over the past 5 years at a rate of 3% per year.
Acelerando crecimiento: Unable to compare HQ8F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: HQ8F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-26.9%).
Rentabilidad financiera
Alta ROE: HQ8F has a negative Return on Equity (-122.23%), as it is currently unprofitable.